How much funding has INDEVR, INC raised?

INDEVR, INC has raised $7.0M in total funding, most recently a Series A round.

Who are INDEVR, INC's investors?

INDEVR, INC's investors include Adjuvant Capital.

When was INDEVR, INC founded?

INDEVR, INC was founded in 2016.

Where is INDEVR, INC headquartered?

INDEVR, INC is headquartered in BOULDER, Colorado, United States.

What industry is INDEVR, INC in?

INDEVR, INC operates in Biotech, Healthcare, Biotechnology.

How many employees does INDEVR, INC have?

INDEVR, INC has 11-50 employees.

INDEVR, INC

Multiplexed Solutions for Vaccine Testing

BOULDER, United States · Founded 2016 · $7.0M raised

Biotech

Healthcare

Biotechnology

Headquarters: BOULDER, Colorado
Employees: 11–50
Founded: 2016
Business Model: B2B

Website: indevr.com
Total Funding: $7.0M
Last Round: $7.0M Series ASep 2019
Rounds: 1

About

InDevR develops multiplexed analytical solutions that accelerate the development and manufacturing of vaccines and biotherapeutics. Its flagship VaxArray Platform delivers rapid, GMP-compliant multiplex immunoassay results for mRNA, polysaccharide, conjugate, and viral vector vaccines. In February 2026, the company was acquired by SSI Diagnostica Group, a global provider of infectious disease testing solutions.

Summary

INDEVR, INC is a Biotech company based in BOULDER, United States, founded in 2016. It has raised $7.0M in total across 1 round, most recently a $7.0M Series A round in Sep 2019. Investors include Adjuvant Capital.

LinkedIn X (Twitter)